Results 161 to 170 of about 95,906 (268)

Increased EGFR/HER2 Pathway Activation Contributes to Skin Tumorigenesis in <i>Tpl2</i>^-^/- Mice. [PDF]

Cancers (Basel)
Purkey LR, Mehedincu S, Irvine C, Akdag R, Little M, Kothmann WW, Rus K, Greenberg E, Shady N, DeCicco-Skinner K.   +9 more
europepmc   +1 more source

On the Modulatory Roles of Neuregulins/ErbB Signaling on Synaptic Plasticity [PDF]

, 2019
Ada Ledonne, Nicola Biagio Mercuri
openalex   +1 more source

Single-cell profiling of ERBB family receptors identifies ERBB3 as a key regulator in head and neck squamous cell carcinoma progression. [PDF]

Discov Oncol
Luo Y, Li Y, Liu S, Hu R, Wu J.
europepmc   +1 more source

Expression of P53 and C-erbB-2 and their significances in chronic atrophic gastritis

, 2006
Song Zhao, Yingmei Fu, Bai Zhao, Lianxin Liu   +3 more
openalex   +1 more source

Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi [PDF]

, 1996
Gaëtan MacGrogan, L. Mauriac, M. Durand, F. Bonichon, M Trojani, I. de Mascarel, Jean‐Michel Coindre   +6 more
openalex   +1 more source

Surface plasmon resonance microscopy reveals N-glycosylation driven modulation of affinity and avidity of ErbB receptors in whole single pancreatic cancer cells. [PDF]

Glycobiology
Aguilar Díaz de León JS, Thirumurthy M, Ly N.   +2 more
europepmc   +1 more source

Regulation Mechanism of ErbB-Hergulin Interaction Shown by Single-molecule Kinetic Analysis in Living Cells

, 2013
Michio Hiroshima, Yasushi Sako
openalex   +2 more sources

A computational model on the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-induced ErbB signalling [PDF]

, 2003
Mariko Hatakeyama, Shuhei Kimura, Takashi Naka, Takuji Kawasaki, Noriko Yumoto, Mio Ichikawa, Jaehoon Kim, Kazuki Saito, Mihoro Saeki, Mikako Shirouzu, Shigeyuki Yokoyama, Akihiko Konagaya   +11 more
openalex   +1 more source

ERBB family fusions are recurrent and actionable oncogenic targets across cancer types

, 2023
Laura Schubert, Andrew Elliott, Anh T. Le, Adriana Estrada‐Bernal, Robert C. Doebele, Emil Lou, Hossein Borghaei, Michael J. Demeure, Razelle Kurzrock, Joshua E. Reuss, Sai‐Hong Ignatius Ou, David R. Braxton, Christian A. Thomas, Sourat Darabi, W. Michael Korn, Wafik S. El‐Deiry, Stephen V. Liu   +16 more
openalex   +1 more source

ErbB signaling and cell cycle pathways associated with trastuzumab deruxtecan resistance in HER2-positive metastatic breast cancer: a case report. [PDF]

AME Case Rep
Gao HF, Lin YY, Lv XZ, Li H, Xu FP, Wang K.   +5 more
europepmc   +1 more source